Pooja Khandelwal, MD

Member, Division of Bone Marrow Transplantation and Immune Deficiency

Academic Affiliations

Assistant Professor, UC Department of Pediatrics

Phone 513-803-9063

Fax 513-803-1969

Email pooja.khandelwal@cchmc.org


Pediatric bone marrow transplantation; acute graft versus host disease



Acute graft versus host disease biology; treatment of steroid refractory acute graft versus host disease; management of refractory autoimmune cytopenias in the post-transplant setting

MD: Kasturba Medical College, Manipal, India, 2005.

Residency: University of Arizona College of Medicine, Tucson, AZ, 2010.

Fellowship: Cincinnati Children's Hospital Medical Center, 2013.

View PubMed Publications

Khandelwal P, Smiley K, Fieno A, Grant R, Davies SM. CXCL10 can be detected non-invasively from the skin of children with acute skin graft versus host disease. Bone Marrow Transplant. 2016 Oct;51(10):1379-1381.

Khandelwal P, Fukuda T, Mizuno K, Teusink-Cross A, Mehta PA, Marsh RA, Kashuba A, Vinks AA, Davies SM. A pharmacokinetic and pharmacodynamic study of maraviroc as acute graft versus host disease prophylaxis in pediatric allogeneic stem cell transplant recipients with non-malignant diagnoses. Biol Blood Marrow Transplant. 2016 Aug 3.

Khandelwal P, Emoto C, Fukuda T, Vinks AA, Neumeier L, Dandoy CE, El-Bietar J, Chandra S, Davies SM, Bleesing JJ, Jordan MB, Mehta PA, Jodele S, Grimley MS, Kumar A, Myers KC, Marsh RA. A Prospective Study of Alemtuzumab as a Second Line Agent for Steroid Refractory Acute Graft Versus Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplant. Biol Blood Marrow Transplant. 2016 Sep 21.

Khandelwal P, Bleesing JJ, Davies SM, Marsh RA. A Single-Center Experience Comparing Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning with Myeloablative Busulfan, Cyclophosphamide, and Antithymocyte Globulin for Chronic Granulomatous Disease. Biol Blood Marrow Transplant. 2016 Nov;22(11):2011-2018. 

Khandelwal P, Lane A, Chaturvedi V, Owsley E, Davies SM, Marmer D,Filipovich AJ, Jordan MB, Marsh RA. Peripheral blood expansion of CD38 bright CD8+ effector memory T- cells predicts acute graft versus host disease. Biol Blood Marrow Transplant. 2015 Jul;21(7):1215-22.

Khandelwal P, Mellor-Heineke S, Rehman N, Lane A, Smiley K, Villanueva J, Marsh RA, Grimley MS, Davies SM, Filipovich AH. Cytokine Profile of Engraftment Syndrome in Pediatric Hematopoietic Stem Cell Transplant Recipients. Biol Blood Marrow Transplant. 2015 Dec 29. pii: S1083-8791(15)01911-4.

Khandelwal P, Marsh RA, Davies SM, Jodele S, Grimley MS, Jordan MB, Filipovich AJ. Bortezomib for refractory autoimmunity in pediatrics. Biol Blood Marrow Transplant. 2014 Oct;20(10):1654-9.

Khandelwal P, Marsh R, Schmid DS, Folster J, Radford KW, Davies SM, Filipovich A. Non dermatomal rash and pancytopenia in a 5 year old child. J Clin Virol. 2014 Jun;60(2):81-3.

 Khandelwal P, Brewer AJ, Minevich E, Miles L, Geller JI. High-grade transitional cell carcinoma of the bladder in a 5 year old successfully treated with partial cystectomy and intravesical Bacillus Calmette-Guerin. Journal of Pediatric Hematology/Oncology. 2014 May;36(4):e234-6.

Khandelwal P, Lawrence J , Filipovich AH, Davies SM, Bleesing, Jordan MB, Mehta PA ,Jodele S,  Grimley MS,  Kumar A,  Myers K, Marsh RA. The successful use of Alemtuzumab for treatment of steroid refractory acute graft versus host disease in pediatric patients. Pediatr Transplant. 2014 Feb;18(1):94-102.